Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Ellis

Showing results (171-180 of 285) with videos related to

Pageof 29
Sort By:
Molecular Endocrinology (Baltimore, Md.)|August 23, 2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomicsMohan Liu, Paul E Goss, James N Ingle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast CancerXian Wang, Jamunarani Veeraraghavan, Chia-Chia Liu, et al.
World Journal of Surgery|January 24, 2021
Definition and Analysis of Textbook Outcome: A Novel Quality Measure in Kidney TransplantationSamantha E Halpern, Dimitrios Moris, Brian I Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statementSteven E Come, Aman U Buzdar, Carlos L Arteaga, et al.
The New England Journal of Medicine|October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancerDaniel F Hayes, Ann D Thor, Lynn G Dressler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Michael Naughton, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Nature Communications|January 31, 2023
Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancerChristopher J Hanley, Sara Waise, Matthew J Ellis, et al.
PNAS Nexus|September 25, 2024
Death-associated protein kinase 3 modulates migration and invasion of triple-negative breast cancer cellsJunkai Wang, Anh M Tran-Huynh, Beom-Jun Kim, et al.
Pageof 29

Showing results (171-180 of 285) with videos related to

Sort By:
Pageof 29
Molecular Endocrinology (Baltimore, Md.)|August 23, 2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomicsMohan Liu, Paul E Goss, James N Ingle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast CancerXian Wang, Jamunarani Veeraraghavan, Chia-Chia Liu, et al.
World Journal of Surgery|January 24, 2021
Definition and Analysis of Textbook Outcome: A Novel Quality Measure in Kidney TransplantationSamantha E Halpern, Dimitrios Moris, Brian I Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statementSteven E Come, Aman U Buzdar, Carlos L Arteaga, et al.
The New England Journal of Medicine|October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancerDaniel F Hayes, Ann D Thor, Lynn G Dressler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Michael Naughton, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Nature Communications|January 31, 2023
Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancerChristopher J Hanley, Sara Waise, Matthew J Ellis, et al.
PNAS Nexus|September 25, 2024
Death-associated protein kinase 3 modulates migration and invasion of triple-negative breast cancer cellsJunkai Wang, Anh M Tran-Huynh, Beom-Jun Kim, et al.
Pageof 29